Skip to main content
Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
129.20
+0.20 (0.16%)
Apr 28, 2025, 3:18 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,5802,436----
Enterprise Value
2,6232,496----
Last Close Price
129.00121.80----
PE Ratio
32.3130.51----
Forward PE
-24.86----
PS Ratio
6.556.18----
PB Ratio
7.016.62----
P/TBV Ratio
8.127.67----
P/FCF Ratio
106.94100.97----
P/OCF Ratio
73.1069.02----
EV/Sales Ratio
6.666.33----
EV/EBITDA Ratio
26.4725.19----
EV/EBIT Ratio
29.3727.95----
EV/FCF Ratio
108.71103.45----
Debt / Equity Ratio
0.180.180.200.300.330.25
Debt / EBITDA Ratio
0.660.660.731.111.050.72
Debt / FCF Ratio
2.712.710.861.443.445.49
Asset Turnover
0.800.800.760.700.73-
Inventory Turnover
1.681.681.441.371.45-
Quick Ratio
1.851.851.491.361.591.52
Current Ratio
2.652.652.362.222.302.66
Return on Equity (ROE)
23.67%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
11.39%11.39%10.83%10.10%12.09%-
Return on Capital (ROIC)
13.91%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
22.70%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
3.09%3.28%----
FCF Yield
0.94%0.99%----
Dividend Yield
1.94%1.64%----
Payout Ratio
18.79%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
1.94%1.64%----
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.